報價延遲最少15分鐘:2025/05/18 12:28 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.71 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.00/-1.78
|
|
企業價值
320.87M
|
| 資產負債 |
|
每股賬面淨值
5.61
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/05/18 12:28 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline. |